Inpatient rehabilitation therapy among colorectal cancer patients – utilization and association with prognosis: a cohort study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Brenner H, Bouvier AM, Foschi R, EUROCARE Working Group, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer. 2012;131(7):1649–1658.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Arndt V, Merx H, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol. 2004;22(23):4829–4836.
   PubMed Web of Science ®Google Scholar
• Thong MSY, Koch-Gallenkamp L, Jansen L, et al. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls – a population-based study. Acta Oncol. 2019;58(5):801–810.
   PubMed Web of Science ®Google Scholar
• Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470.
   PubMed Web of Science ®Google Scholar
• Jansen L, Herrmann A, Stegmaier C, et al. Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol. 2011; 29(24):3263–3269.
   PubMed Web of Science ®Google Scholar
• Custers JAE, Gielissen MFM, Janssen SHV, et al. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. 2016;24(2):555–562.
   PubMed Web of Science ®Google Scholar
• Jansen L, Koch L, Brenner H, et al. Quality of life among long-term (≥5 years) colorectal cancer survivors-systematic review. Eur J Cancer. 2010;46(16):2879–2888.
   PubMed Web of Science ®Google Scholar
• Rothbarth J, Bemelman WA, Meijerink WJ, et al. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum. 2001;44(1):67–71.
   PubMed Web of Science ®Google Scholar
• Hellbom M, Bergelt C, Bergenmar M, et al. Cancer rehabilitation: a Nordic and European perspective. Acta Oncol. 2011;50(2):179–186.
   PubMed Web of Science ®Google Scholar
• Stubblefield MD, Hubbard G, Cheville A, et al. Current perspectives and emerging issues on cancer rehabilitation. Cancer. 2013;119 Suppl 11:2170–2178.
   PubMed Web of Science ®Google Scholar
• Cheville AL, Mustian K, Winters-Stone K, et al. Cancer rehabilitation: an overview of current need, delivery models, and levels of care. Phys Med Rehabil Clin N Am. 2017;28(1):1–17.
   PubMed Web of Science ®Google Scholar
• Cheville AL, Beck LA, Petersen TL, et al. The detection and treatment of cancer-related functional problems in an outpatient setting. Support Care Cancer. 2009;17(1):61–67.
   PubMed Web of Science ®Google Scholar
• Rick O, Dauelsberg T, Kalusche-Bontemps EM. Oncological rehabilitation. Oncol Res Treat. 2017;40(12):772–777.
   PubMed Web of Science ®Google Scholar
• German-Pension-Insurance. Reha-Bericht 2018 [Rehabilitation-Report 2018]. Berlin (Germany); 2018. p. 73–88 (German).
   Google Scholar
• Wehner C. Die Rehabilitation der gesetzlichen Rentenversicherung in Geschichte und Gegenwart: Eine Einführung [The rehabilitation by the statutory pension insurance in history and present: an introduction]. In: Wehner C, editor. Aufbrüche in der Rehabilitation. Geschichte und Gegenwart der Rehabilitationin der gesetzlichen Rentenversicherung [Departures in rehabilitation. the past and present of rehabilitation in the statutory pension insurance]. Bochum (Germany): Documentation- and Research Agency of the Social Security Institutions; 2019. p. 7–24 (German).
   Google Scholar
• Geyer S, Schlanstedt-Jahn U. Gibt es soziale Ungleichheiten in der Inanspruchnahme der onkologischen Rehabilitation bei Mammakarzinompatientinnen? [Are there social inequalities in the utilisation of oncological rehabilitation by breast cancer patients?]. Gesundheitswesen. 2012;74(2):71–78 (German).
   PubMed Web of Science ®Google Scholar
• Lehmann C, Beierlein V, Hagen-Aukamp C, et al. Psychosoziale Einflussfaktoren für die Inanspruchnahme medizinischer Rehabilitationsmaßnahmen bei Patienten mit einer Prostatakrebserkrankung [Psychosocial predictors of utilization of medical rehabilitation services among prostate cancer patients]. Rehabilitation. 2012;51(3):160–170.
   PubMed Web of Science ®Google Scholar
• Deck R, Babaev V, Katalinic A. Gründe für die Nichtinanspruchnahme einer onkologischen Rehabilitation. Ergebnisse einer schriftlichen Befragung von Patienten aus onkologischen Versorgungszentren [Reasons for the non-utilisation of an oncological rehabilitation. results of a written survey with patients of oncological healthcare centers]. Rehabilitation. 2019;58(4):243–252.
   PubMed Web of Science ®Google Scholar
• Waldmann A, Lautz E, Hampe J, et al. Popgen-Darmkrebs: Reha-Inanspruchnahme von jüngeren Patienten mit kolorektalem Tumor [Utilization of inpatient rehabilitation of younger patients with colorectal neoplasms – results of the project “Popgen-Colorectal Cancer”]. Rehabilitation. 2007;46(6):349–355.
   PubMedGoogle Scholar
• Nowossadeck E, Barnes B. Inanspruchnahme der onkologischen Rehabilitation im Verhältnis zur Krebsinzidenz. [Utilization of oncological rehabilitation in relation to cancer incidence]. Gesundheitswesen. 2016;78(08/09):A163.
   Web of Science ®Google Scholar
• Scherer S, Jansen L, Boakye D, et al. Changes in health-related outcomes among colorectal cancer patients undergoing inpatient rehabilitation therapy: a systematic review of observational and interventional studies. Acta Oncol. 2021; 60(1):124–134.
   PubMed Web of Science ®Google Scholar
• Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–717.
   PubMed Web of Science ®Google Scholar
• Hoffmeister M, Jansen L, Rudolph A, et al. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst. 2015;107(6):djv045.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Diss. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Weberpals J, Jansen L, Silversmit G, et al. Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patients. Clin Epidemiol. 2018;10:1109–1125.
   PubMed Web of Science ®Google Scholar
• Suissa SJA. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492–499.
   PubMed Web of Science ®Google Scholar
• Owens WD, Felts JA, Spitznagel EL. Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239–243.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Abelmann WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1948;1(4):634–656.
   Web of Science ®Google Scholar
• Boakye D, Walter V, Martens UM, et al. Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses. Clin Epidemiol. 2019;11:821–832.
   PubMed Web of Science ®Google Scholar
• World-Health-Organization. International classification of functioning, disability and health. Geneva (Switzerland); ICF; 2001. p. 8.
   Google Scholar
• Ture M, Barth J, Angst F, et al. Use of inpatient rehabilitation for cancer patients in Switzerland: who undergoes cancer rehabilitation? Swiss Medical Weekly. 2015;145:w14214.
   PubMed Web of Science ®Google Scholar
• Cheville AL, Troxel AB, Basford JR, et al. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26(16):2621–2629.
   PubMed Web of Science ®Google Scholar
• Spill GR, Hlubocky FJ, Daugherty CK. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer. Pm R. 2012;4(2):96–108.
   PubMedGoogle Scholar
• Weis J, Dresch C, Bartsch HH, et al. Barrieren der Antragstellung in der Onkologischen Rehabilitation: Eine bundesweite Expertenstudie [Barriers in the application process for oncological rehabilitation: a nationwide expert study]. Rehabilitation. 2021;60(2):95–101.
   PubMed Web of Science ®Google Scholar